English newsitems
Veramaris started the manufacturing of natural marine algae through fermentaion.

Veramaris, the joint venture between DSM and Evonik, has started the production of algal oil containing omeg-3 fatty acids. The oil is a result of the fermentative manufacturing of natural marine algae. The oil processed with these algea is fed mainly to salmon.

The two parent companies DSM and Evonik have invested a total of 200 million US dollars in equal parts for the construction of the fermentation plant in Blair, Nebraska. The initial algal oil produced at the plant can sustainably supply approximately 15 percent of the annual demand the global salmon-farming industry has for the two omega-3 fatty acids EPA and DHA. The unique process developed by Evonik and DSM enables the manufacture of EPA and DHA for salmon feed for the first time without using any fish oil from wild-caught fish.


Feike Sijbesma, CEO/Chairman DSM Managing Board commented: “I am pleased that together with Evonik we have reached a key milestone in turning the tide: through Veramaris, we are able to reduce the aquaculture industry’s reliance on the world’s finite fish oil resources for these vital omega-3 fatty acids. This fits perfectly with our purpose-led performance driven strategy, focused on addressing the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all our stakeholders.”

“In Veramaris, we have combined the competencies of two strong partners to make an innovative contribution to the healthy nutrition of the world’s growing population, without putting any further burden on our oceans,” says Christian Kullmann, chairman of the Executive Board of Evonik.


The production of the Veramaris algal oil is based on the natural algae strain Schizochytrium, which DSM has brought to the partnership with Evonik. The joint development of the strain right up to commercial production, and the joint development of the process formed the basis for the new production plant. The plant on site in Blair next to an Evonik facility for the production of Biolys, a source of L-lysine. The production complex benefits from many synergies in infrastructure, technology and personnel.

The algal oil produced by Veramaris enables the reduction of the fish oil share without impacting the omega-3 fatty acid content in the farmed fish.

Also read: DSM and Evonik start joint venture in omega-3 fatty acids

Geef een reactie

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

Deze website gebruikt Akismet om spam te verminderen. Bekijk hoe je reactie-gegevens worden verwerkt.